Aquestive Therapeutics
AQST
#6498
Rank
โ‚ฌ0.63 B
Marketcap
5,24ย โ‚ฌ
Share price
-7.85%
Change (1 day)
42.23%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2025 (TTM): โ‚ฌ38.86 Million

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ37.29 Million. In 2024 the company made a revenue of โ‚ฌ55.31 Million an increase over the revenue in the year 2023 that were of โ‚ฌ45.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ38.86 M-29.74%
2024 โ‚ฌ55.31 M20.89%
2023 โ‚ฌ45.75 M2.94%
2022 โ‚ฌ44.44 M-0.97%
2021 โ‚ฌ44.88 M20.41%
2020 โ‚ฌ37.27 M-20.63%
2019 โ‚ฌ46.96 M-20.32%
2018 โ‚ฌ58.94 M5.68%
2017 โ‚ฌ55.77 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.55 B 1,379.52%๐Ÿ‡บ๐Ÿ‡ธ USA